BioSpace News Archive

Press Releases

PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer

October 21, 2025
·
21 min read
Press Releases

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

October 21, 2025
·
8 min read
Press Releases

Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules

October 21, 2025
·
6 min read
Press Releases

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - October 21, 2025

October 21, 2025
·
1 min read
Press Releases

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders

October 21, 2025
·
2 min read
Press Releases

InspireMD to Announce Third Quarter 2025 Financial Results

October 21, 2025
·
1 min read
Press Releases

Intuitive Announces Third Quarter Earnings

October 21, 2025
·
23 min read
Press Releases

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

October 21, 2025
·
7 min read
Press Releases

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

October 21, 2025
·
6 min read
Press Releases

Dr. Juan Fortea discusses his groundbreaking research redefining APOE4 homozygosity as a genetic cause of Alzheimer’s and his upcoming webinar

October 21, 2025
·
4 min read